Rochester, NY 7/30/2009 11:51:07 PM
Mylan, Inc. MYL, Mylan full-year earnings moves higher over Q2
Mylan, Inc. MYL
Thursday report Q2 has amended earnings better analyst prospect. Drugmaker Mylan Inc. increased its yearly profit outlook.
http://WhisperFromWallStreet.com offers daily stock alerts to subscribers. Scroll to bottom of page to sign up for our free alerts newsletter.
Mylan now forecasts a earnings between $1.13 and $1.20 per share, moves up from $1 to $1.10 per share. Analysts are estimating $1.08 per share.
About MYL
Mylan Inc. and its subsidiaries engage in the development, manufacture, marketing, licensing, and distribution of generic, brand, and branded generic pharmaceutical products and active pharmaceutical ingredients (APIs).
WhisperfromWallStreet.com is a FREE award winning newsletter that specializes in sending alerts to our subscribers on stocks we think are going to run, why we think so, as well as teaching you how to become a better trader. We scan hundreds of stocks a day to find those that meet our criteria and when we find one, we send you an alert.
Scroll to the bottom of this page to sign up for our FREE stock alerts newsletter at WhisperfromWallStreet.com
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither WhisperFromWallStreet, nor any of its affiliates are registered investment advisors or broker dealers.
